CD274 and cancer: To determine the impact of SMAD4 loss on additional immune cell processes, particularly those related to cancer immunotherapy, we next explored the relationship between SMAD4 and PD-L1 in vitro, first evaluating the basal expression of PD-L1 in a variety of established PDAC cell lines.